Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07652684 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants

Study acronym: PRELUDE
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The Impact of Omega-3 (DHA - Docosahexaenoic Acid) and Omega-6 (ARA - Arachidonic Acid) Supplementation on the Development of Bronchopulmonary Dysplasia in Extremely and Very Preterm Infants (24-29 weeks of gestational age).
Trial Details
NCT Number NCT07652684
Lead Sponsor Aristotle University Of Thessaloniki
Conditions
(from sponsor)		 Bronchopulmonary Dysplasia (BPD)
Related terms Bronchopulmonary Dysplasia, Premature Birth
Enrollment 74 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov